Brain Activation by Peptide Pro-Leu-Gly-NH(2) (MIF-1)

MIF-1 (Pro-Leu-Gly-NH(2)) is a tripeptide for which the therapeutic potential in Parkinson's disease and depression has been indicated by many studies. However, the cellular mechanisms of action of MIF-1 are not yet clear. Here, we show the specific brain regions responsive to MIF-1 treatment b...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Reas S., Yu, Chuanhui, Kastin, Abba J., He, Yi, Ehrensing, Rudolph H., Hsuchou, Hung, Stone, Kirsten Prufer, Pan, Weihong
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915805/
https://www.ncbi.nlm.nih.gov/pubmed/20721355
http://dx.doi.org/10.1155/2010/537639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915805/
https://www.ncbi.nlm.nih.gov/pubmed/20721355
http://dx.doi.org/10.1155/2010/537639

Ejemplares similares